Skip to content

Author

Anmbreen Jamroze

We have 1 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer

The induction of a bi-phasic response in the TiME is revealed: robust CTL activation 3–5 months after nADT is initiated, followed by myeloid immunosuppression in tumors receiving prolonged nADT.

Anmbreen Jamroze, Ren-Yuan Zhang, Emily M. Dougherty et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.